Request Deal Involvement

Biogen to acquire the remaining 89.8% stake in Sage Therapeutics in a $442m deal.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Joele Frank

pr advisors

Joele Frank

or

Principals

SAGE THERAPEUTICS

target

SAGE THERAPEUTICS

BIOGEN INC

bidder

BIOGEN INC

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Biogen to acquire the remaining 89.8% stake in Sage Therapeutics in a $442m deal.